Trek Therapeutics PBC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.trektx.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection
Phase 2
Completed
- Conditions
- Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1Hepatitis C Viral Infection
- Interventions
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2017-10-17
- Lead Sponsor
- Trek Therapeutics, PBC
- Target Recruit Count
- 25
- Registration Number
- NCT02716428
- Locations
- 🇺🇸
Southern California Research Center, Coronado, California, United States
🇺🇸Bach and Godofsky Infectious Diseases, Bradenton, Florida, United States
🇺🇸Gastro One, Germantown, Tennessee, United States
A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection
Phase 2
Completed
- Conditions
- Hepatitis C Viral InfectionChronic Hepatitis CHepatitis C Genotype 4Hepatitis C (HCV)
- Interventions
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- Trek Therapeutics, PBC
- Target Recruit Count
- 16
- Registration Number
- NCT02593162
- Locations
- 🇺🇸
Southern California Research Center, Coronado, California, United States
News
No news found